Figure 5. Genetic alterations in TA-CDKs and their association with OS and DSS in breast cancer patients (cBioPortal). (A) Summary of alterations in TA-CDKs in different breast cancer types. (B) OncoPrint visual summary of genetic alterations detected in TA-CDKs. (C) Kaplan–Meier curves comparing OS in breast cancer cases with or without genetic alterations in TA-CDKs. (D) Kaplan–Meier curves comparing DSS in breast cancer cases with or without genetic alterations in TA-CDKs.